Home » Newsletters » BioWorld Science

BioWorld Science

May 14, 2004

View Archived Issues

Novel somatostatin conjugate effective for treatment of choroidal neovascularization in vivo

Further data on antitumor activity of PEP-005 supporting use as topical anti-skin cancer agent

Prostanoid compound RUG-015 effectively reduces intraocular pressure

Enrollment closed in Gamunex trial for relapsing-remitting MS

Daiichi launches new Floxin Otic presentation

New findings support rapid onset of action of Levitra

Tularik reports first quarter developments

Spotlight on topiramate in the prevention of migraine

Pharmacokinetics and efficacy of ranibizumab in exudative AMD

Forbes Medi-Tech describes sterol-NSAID conjugates for cardiovascular disease and other uses

New mGluR5/mGluR1 antagonists presented by Euroceltique team

U. of Leiden researchers identify novel inhibitors of GST P1-1

Novel inhibitors of CDK2 and other kinases under study at Schering-Plough

3M scientists develop immune response modifiers for use in viral infections and cancer

Euroceltique claims new analgesic agents with VR1 and mGluR antagonist activity

Non-CNS penetrating mu opioid agonists covered by Euroceltique patent

Enrollment completed in phase III dalbavancin trials

Modified-release lercanidipine to be developed for Japanese market

Ranbaxy launches new strength of DisperMox

FDA approval for Enjuvia NDA

Phase I trial commences for oral CCR2 antagonist INCB-3284

Sonus completes private placement

Orbus acquires Midamor and Moduret in Canada

Partial clinical hold in phase IIa trial of HepeX-C

New low molecular weight compounds with anticancer and antibacterial activity

RNA-TEC and Lonza collaborate on TBDMS-based oligonucleotides

Private placement of BioSante common stock

Studies assess tacrolimus ointment in atopic dermatitis

ECCMID highlights: BAL-9141 not likely to induce resistance in MRSA

Good safety profile of DOV-216303 in healthy volunteers

Preclinical evidence for the efficacy of (S)-tofisopam in menopause and anxiety disorders

Novel PDF inhibitor BB-81384 shows good oral anti-pneumococcal activity and pharmacokinetics

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
UK Biobank delivers largest metabolomics dataset of 500K profiles
BioWorld Science
It’s the biological resource that keeps on giving, and now UK Biobank has released the final tranche of data on the levels of 249 metabolites in the blood of its...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...